Harbour Investments’s Phibro Animal Health PAHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$11K Sell
351
-200
-36% -$8.44K ﹤0.01% 3305
2026
Q1
$30.5K Buy
551
+200
+57% +$9.52K ﹤0.01% 2624
2025
Q4
$13.1K Hold
351
– – ﹤0.01% 2609
2025
Q3
$14.2K Hold
351
– – ﹤0.01% 2517
2025
Q2
$8.96K Hold
351
– – ﹤0.01% 2620
2025
Q1
$7.5K Hold
351
– – ﹤0.01% 2652
2024
Q4
$7.37K Hold
351
– – ﹤0.01% 2590
2024
Q3
$7.91K Buy
351
+231
+193% +$4.46K ﹤0.01% 2461
2024
Q2
$2.01K Buy
+120
New +$1.93K ﹤0.01% 2808
2021
Q4
– Sell
-435
Closed -$9K – 3387
2021
Q3
$9K Buy
+435
New +$10.5K ﹤0.01% 2731

Other funds holding PAHC

Harbour Investments's PAHC Position: Q2 2026 in Review

Harbour Investments reduced its Phibro Animal Health (PAHC) stake by 36% in Q2 2026, selling an estimated $8.44K and leaving 351 shares worth $11K. The position accounts for ﹤0.01% of the portfolio, ranked #3305.

Harbour Investments first reported a position in PAHC in Q3 2021 and has held it in 10 quarters since. The position peaked at $30.5K in Q1 2026. 208 funds tracked by Wall St. Rank hold PAHC as of Q2 2026.

  • Harbour Investments held 351 shares of Phibro Animal Health worth $11K as of Q2 2026.
  • Harbour Investments sold 200 Phibro Animal Health shares in Q2 2026, an estimated $8.44K.
  • Phibro Animal Health made up ﹤0.01% of Harbour Investments's portfolio in Q2 2026, its #3305 holding.
  • Harbour Investments first reported a position in Phibro Animal Health in Q3 2021 and has held it in 10 quarters since.
  • Harbour Investments's Phibro Animal Health position peaked at $30.5K in Q1 2026.
  • 208 funds tracked by Wall St. Rank held Phibro Animal Health as of Q2 2026.

Based on Harbour Investments's 13F filing for Q2 2026, filed 12 Aug 2026.